Standard Chemical & Pharmaceutical Co Ltd Capital Reinvestment Ratio
Standard Chemical & Pharmaceutical Co Ltd capital reinvestment ratio. Standard Chemical & Pharmaceutical Co Ltd (1720) has a Capital Reinvestment Ratio of 0.15x as of September 2025, meaning it reinvests 0% of its operating cash flow (NT$510.55 Million) in capital expenditures (NT$78.71 Million). See 1720 free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Standard Chemical & Pharmaceutical Co Ltd (2002–2024)
Capital reinvestment ratio of Standard Chemical & Pharmaceutical Co Ltd from 2002 to 2024. This chart tracks Standard Chemical & Pharmaceutical Co Ltd's Capital Reinvestment Ratio across 23 annual periods. See financial flexibility index of Standard Chemical & Pharmaceutical Co Lt to measure the company's free cash flow as a share of total liabilities.
Standard Chemical & Pharmaceutical Co Ltd Capital Reinvestment Ratio by Year (2002–2024)
Standard Chemical & Pharmaceutical Co Ltd capital reinvestment ratio by year from 2002 to 2024. For the full cash flow conversion analysis, see cash flow conversion of Standard Chemical & Pharmaceutical Co Lt.
| Year | Reinvestment Ratio | Operating CF (TWD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.35x | NT$1.69 Billion | NT$599.61 Million | ▼ -24.4% |
| 2023 | 0.47x | NT$1.34 Billion | NT$625.70 Million | ▼ -52.0% |
| 2022 | 0.98x | NT$1.23 Billion | NT$1.20 Billion | ▲ +270.2% |
| 2021 | 0.26x | NT$827.03 Million | NT$217.92 Million | ▼ -31.0% |
| 2020 | 0.38x | NT$922.58 Million | NT$352.49 Million | ▲ +36.1% |
| 2019 | 0.28x | NT$637.94 Million | NT$179.11 Million | ▼ -19.6% |
| 2018 | 0.35x | NT$484.94 Million | NT$169.36 Million | ▼ -35.8% |
| 2017 | 0.54x | NT$708.74 Million | NT$385.64 Million | ▼ -6.6% |
| 2016 | 0.58x | NT$305.38 Million | NT$177.92 Million | ▲ +111.9% |
| 2015 | 0.27x | NT$650.87 Million | NT$178.98 Million | ▼ -9.8% |
| 2014 | 0.30x | NT$582.30 Million | NT$177.53 Million | ▼ -69.2% |
| 2013 | 0.99x | NT$427.26 Million | NT$422.73 Million | ▲ +61.3% |
| 2012 | 0.61x | NT$402.25 Million | NT$246.76 Million | ▼ -16.7% |
| 2011 | 0.74x | NT$405.49 Million | NT$298.50 Million | ▼ -35.2% |
| 2010 | 1.14x | NT$272.47 Million | NT$309.66 Million | ▲ +170.8% |
| 2009 | 0.42x | NT$634.23 Million | NT$266.14 Million | ▲ +56.8% |
| 2008 | 0.27x | NT$719.17 Million | NT$192.50 Million | ▲ +19.1% |
| 2007 | 0.22x | NT$323.60 Million | NT$72.72 Million | ▼ -15.1% |
| 2006 | 0.26x | NT$358.75 Million | NT$95.01 Million | ▲ +93.4% |
| 2005 | 0.14x | NT$370.77 Million | NT$50.78 Million | ▲ +12.2% |
| 2004 | 0.12x | NT$335.45 Million | NT$40.95 Million | ▼ -77.8% |
| 2003 | 0.55x | NT$272.89 Million | NT$149.81 Million | ▼ -57.9% |
| 2002 | 1.30x | NT$147.75 Million | NT$192.54 Million | — |